Malfertheiner, Peter, 1950-....
Peter Malfertheiner researcher
Malfertheiner, P. (Peter), 1950-
Malfertheiner, P.
Malfertheiner, P. (Peter)
VIAF ID: 111519306 (Personal)
Permalink: http://viaf.org/viaf/111519306
Preferred Forms
- 200 _ | ‡a Malfertheiner ‡b Peter ‡f 1950-....
-
-
-
- 100 1 _ ‡a Malfertheiner, P. ‡q (Peter)
-
- 100 1 _ ‡a Malfertheiner, P. ‡q (Peter), ‡d 1950-
-
-
- 100 1 _ ‡a Malfertheiner, Peter ‡d 1950-
- 100 1 _ ‡a Malfertheiner, Peter ‡d 1950-
- 100 1 _ ‡a Malfertheiner, Peter ‡d 1950-
-
- 100 1 _ ‡a Malfertheiner, Peter, ‡d 1950-....
- 100 0 _ ‡a Peter Malfertheiner ‡c researcher
4xx's: Alternate Name Forms (11)
5xx's: Related Names (1)
Works
Title | Sources |
---|---|
Aging and the gastrointestinal tract | |
Basic mechanisms of digestive diseases the rationale for clinical management and prevention | |
Campylobacter pylori in gastroduodenal diseases : current views - future directions : proceedings of an International Workshop in Copenhagen October 15 and 16, 1987 | |
Challenges in inflammatory, preneoplastic and neoplastic diseases of the digestive system 19 tables | |
Diagnostic procedures in pancreatic disease | |
Diseases of the pancreas : acute pancreatitis, chronic pancreatitis, neoplasms of the pancreas | |
Fusobacterium nucleatum is associated with worse prognosis in Lauren´s diffuse type gastric cancer patients | |
Gastrointestinal oncology and innovative aspects in gastroenterology | |
GERD assessment including pH metry predicts a high response rate to PPI standard therapy | |
Gut microbiota profiles and the role of anti-CdtB and anti-vinculin antibodies in patients with functional gastrointestinal disorders (FGID) | |
H. PYLORI ERADICATION HAS THE POTENTIAL TO PREVENT GASTRIC CANCER | |
H. pylori infection is a key risk factor for proximal gastric cancer | |
Hauptthema Das Karzinom am ösophagogastralen Übergang eingeladene Beiträge, interdisziplinäres Gespräch | |
Helicobacter pylori and non-malignant diseases | |
Helicobacter pylori, Gastritis and Peptic Ulcer | |
Helicobacter pylori infection new facts - new views | |
Helicobacter pylori - od podstaw do leczenia : cechy charakterystyczne, patogeneza, wykrywanie, eradykacja | |
Helicobacter pylori vacA genotype is a predominant determinant of immune response to Helicobacter pylori CagA. | |
Helicobacter pylori von der Grundlage zur Therapie ; Eigenschaften, Pathogenese, Nachweis, Eradikation ; 52 Tabellen | |
Hepatocellular carcinoma and liver cirrhosis: assessment of the liver function after Yttrium-90 radioembolization with resin microspheres or after CT-guided high-dose-rate brachytherapy. | |
Hepatocellular carcinoma--epidemiological trends and risk factors | |
Iceman's Last Meal Consisted of Fat, Wild Meat, and Cereals | |
Identification of enterohepatic Helicobacter species in patients suffering from inflammatory bowel disease | |
Identification of gastric cancer patients by serum protein profiling | |
Impact of endoscopy-based research on quality of life in healthy volunteers | |
Impact of Extrahepatic Metastases on Overall Survival in Patients with Advanced Liver Dominant Hepatocellular Carcinoma: A Subanalysis of the SORAMIC Trial | |
Impact of gastroesophageal reflux disease symptoms on the quality of life in pregnant women: a prospective study | |
Impact of high-resolution transabdominal ultrasound in the diagnosis of complications of Crohn's disease | |
Increased beta-catenin mRNA levels and mutational alterations of the APC and beta-catenin gene are present in intestinal-type gastric cancer. | |
Influence of cyclooxygenase inhibitors on the function of the prostaglandin transporter organic anion-transporting polypeptide 2A1 expressed in human gastroduodenal mucosa | |
Influence of laboratory-related and endoscopy-related factors on the assessment of serum pepsinogens and gastrin-17. | |
Inhibition of RICK/nuclear factor-kappaB and p38 signaling attenuates the inflammatory response in a murine model of Crohn disease. | |
International comparison of the German evidence-based S3-guidelines on the diagnosis and multimodal treatment of early and locally advanced gastric cancer, including adenocarcinoma of the lower esophagus | |
An international primary care survey of GERD terminology and guidelines | |
Lectin UEA-I-binding proteins are specifically increased in the squamous epithelium of patients with Barrett's esophagus | |
Liver cell cancer | |
Long-term results with a new introducer method with gastropexy for percutaneous endoscopic gastrostomy. | |
Loss of expression of tumor suppressor p16 | |
Macro-role of microRNA in gastric cancer | |
Maintenance therapy with FOLFIRI after FOLFIRINOX for advanced pancreatic ductal adenocarcinoma : a retrospective single-center analysis | |
Management of portal hypertension | |
Metabolic and autoimmune diseases of the digestive system selected articles from the EAGE postgraduate courses Opatija and Prag 2011 ; 14 tables | |
A multicenter, phase II study of infliximab plus gemcitabine in pancreatic cancer cachexia | |
New developments in the management of gastric cancer 18 tables | |
A novel approach to esophageal stent removal in the setting of proximal stenosis and failure of the primary retrieval mechanism | |
Pancreatic cancer : an update | |
Pankreaserkrankungen akute Pankreatitis, chronische Pankreatitis, Tumore des Pankreas ; 87 Tabellen | |
Pankreatin Enzymsubstitution bei exokriner Pankreasinsuffizienz | |
Performance and value of IFN-lambda3 and IFN-lambda4 genotyping in patients with chronic hepatitis C (CHC) genotype 2/3 in a real world setting | |
The pH-Hp challenge - from mechanism to management : proceedings of a symposium held in Copenhagen, Denmark, 29 April 1995 | |
Prevention and progress in management of gastrointestinal cancers | |
A prospective longitudinal cohort study: evolution of GERD symptoms during the course of pregnancy | |
Proton pump inhibitors a balanced view | |
A Randomised, Controlled Trial: Effect of a Multi-Strain Fermented Milk on the Gut Microbiota Recovery after Therapy | |
A randomized, comparative study of three doses of AZD0865 and esomeprazole for healing of reflux esophagitis | |
The Regulation of cell proliferation and differentiation : from basic science to clinical implications | |
Safety and toxicity of radioembolization plus Sorafenib in advanced hepatocellular carcinoma: analysis of the European multicentre trial SORAMIC. | |
Standards in pancreatic surgery | |
Troglitazone inhibits tumor growth in hepatocellular carcinoma in vitro and in vivo | |
Unmet medical needs among patients with gastroesophageal reflux disease: a foundation for improving management in primary care | |
Update gastroenterology 2006 novel developments in gastroenterology | |
Upregulation of cathepsin W-expressing T cells is specific for autoimmune atrophic gastritis compared to other types of chronic gastritis | |
Upregulation of leukotriene receptors in gastric cancer | |
Usefulness of the double-balloon enteroscope in colonoscopies performed in patients with previously failed colonoscopy. | |
Validation of Hepa-index as a non-invasive biomarkers panel for assessment of hepatic fibrosis in Egyptians with chronic hepatitis C. | |
Validation of Two Calprotectin Rapid Tests in Daily Routine. | |
Zonulin is not increased in the cardiac and esophageal mucosa of patients with gastroesophageal reflux disease |